OPEN-LABEL PHASE 3 CLINICAL STUDY TO INVESTIGATE SAFETY AND IMMUNOGENICITY OF A SINGLE VLA2001 BOOSTER VACCINATION IN VOLUNTEERS AGED ≥18 YEARS, AFTER NATURAL SARS-COV-2 INFECTION OR RECEIPT OF NATIONALLY ROLLED OUT mRNA COVID-19 VACCINES.

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2022
This article has no abstract
Epistemonikos ID: 94896f77e1b24608351c8d2d0210c7546c335c4e
First added on: Apr 19, 2022